1.External ocular manifestations among patients diagnosed with Coronavirus disease 2019 in a referral center in the Philippines.
Alyssa Louise B. Pejana-Paulino ; Aramis B. Torrefranca Jr. ; Nilo Vincent DG. Florcruz ; Ma. Dominga B. Padilla
Acta Medica Philippina 2026;60(1):69-77
BACKGROUND AND OBJECTIVES
The global pandemic caused by Coronavirus Disease 2019 (COVID-19) has affected millions, with growing evidence of the potential role of ocular tissues in viral transmission. At the time of writing, local data regarding the phenomenon was limited. This study investigated external ocular manifestations in patients with COVID-19 at a referral center in the Philippines, examined correlations between demographics, systemic manifestations, and laboratory results with ocular manifestations, and determined their timing relative to systemic symptoms.
METHODSThis single-center, descriptive cross-sectional study was carried out from December 8 to 18, 2020 at the adult COVID-19 wards of the Philippine General Hospital involving 72 participants. Data collection involved relevant clinical history taking and performing gross eye examination. The prevalence of ocular manifestations was described with 95% confidence intervals. Correlations between ocular manifestations and quantitative variables were analyzed with point-biserial correlation, and associations with qualitative variables were tested using chi-square or Fisher’s exact tests.
RESULTSAmong participants, 31.9% presented with ocular manifestations with foreign body sensation as the most prevalent ocular symptom (11.1%) and conjunctival hyperemia as the most prevalent ocular finding (19.4%). The median age of patients with ocular manifestations was 41 years old with a higher prevalence in the male population (73.9%, CI=95%, p=0.001). No significant correlation was observed between presence of external ocular manifestations and the different systemic and ocular co-morbidities as well as with COVID-19 clinical classification. Among those who experienced symptoms, majority (29.2%) of the patients experienced systemic symptoms prior to the onset of ocular symptoms. Ocular complaints may present as the sole manifestation (13.9%). Several laboratory parameters were measured and only temperature and AST levels showed a low positive correlation with the presence of ocular manifestations.
CONCLUSIONOcular manifestations occur in roughly one third of patients with COVID-19 based on this study population. With some individuals presenting with ocular signs or symptoms as the initial and sole manifestation, healthcare practitioners must exercise caution and remain vigilant in managing patients who present as such. At the time of writing, this is the first local study investigating the different external ocular manifestations in patients with COVID-19. There is a need to pursue more robust studies and conduct more local investigations which will guide both ophthalmologists and other practitioners in strengthening existing guidelines regarding precautionary practices, clinical diagnosis, and management of COVID-19 patients.
Human ; Sars-cov-2 ; Covid-19 ; Philippines ; Adult ; Association ; Classification ; Collection ; Confidence Intervals ; Coronavirus ; Cross-sectional Studies ; Data Collection ; Demography ; Diagnosis ; Disease ; Exercise ; Eye ; Foreign Bodies ; History ; Hospitals ; Hospitals, General ; Hyperemia ; Laboratories ; Male ; Morbidity ; Ophthalmologists ; Pandemics ; Patients ; Population ; Prevalence ; Referral And Consultation ; Role ; Sensation ; Temperature ; Time ; Tissues ; Volition ; World Health Organization ; Writing
2.Clinical profile and outcomes of patients with chronic kidney disease on chronic hemodialysis hospitalized for acute coronary syndrome in a tertiary public hospital in the Philippines.
Jerahmeel Aleson L. Mapili ; Cecileen Anne M. Tuazon ; Paul Anthony O. Alad ; John Christopher A. Pilapil ; Bianca M. Velando ; Azel Paolo T. Bondoc ; Lloyd Christopher S. Lim ; Marie Aisen Kathrina B. Cabujat-Bumanglag ; Vincent Anthony S. Tang ; Janice Jill K. Lao ; John C. Anonuevo
Acta Medica Philippina 2026;60(4):24-34
INTRODUCTION
Acute coronary syndrome (ACS) and end-stage renal disease (ESRD) are both prevalent globally. The diagnosis and management of ACS in ESRD is difficult because the interplay of cardiovascular and renal disease is complicated. The guidelines for ACS may not be applicable to the ESRD population because the trials from which these are drawn mostly excluded ESRD patients.
OBJECTIVETo determine the clinical profile and outcomes of CKD patients on dialysis admitted for ACS in the Philippine General Hospital (PGH).
METHODSWe did a retrospective cohort study and employed a retrospective review of electronic medical records among ESRD patients presenting with ACS in PGH from May 2021 to November 2023. The collected data was analyzed using univariate and bivariate statistics using PRISM software.
RESULTSA total of 48 patients with ESRD were admitted for ACS in this study – 8 with STEMI and 40 with NSTEMI. The mean age was 61 years old and 33 (68.8%) were male. Among those with STEMI, six (75%) presented with Kilip II or more. While among those with NSTEMI, 17 (42.5%) had a GRACE score >140 and 27 (67.5%) had an NSTEMI TIMI risk score >2. On average, the patients were on hemodialysis for 31 months prior to admission. The most common comorbidities were hypertension (91.7%) and heart failure (83.3%). On admission, 18 (37.5%) presented with SBP >160, 7 (14.6%) patients presented with shock, and 4 (8.3%) patients presented with cardiac arrest. 38 (79.2%) patients had anemia on admission. 21 (43.8%) patients had left ventricular hypertrophy on electrocardiogram while 34 (70.8%) patients had cardiomegaly on chest radiography. The average left ventricular ejection fraction on echocardiogram was 46% and 27 (90%) patients had segmental wall motion abnormalities. The most common angiographic finding was 3-vessel coronary artery disease seen in 50% of patients. Almost all patients received dualantiplatelet therapy, high dose statin, and beta-blocker. The mortality rate was high at 43.8% with cardiovascular causes being the most common cause of death.
CONCLUSIONThis study demonstrates the high mortality rate among patients with ESRD presenting with ACS. Our study portrays that patients with ESRD present with higher risk features including abnormalities in vital signs, laboratories, imaging, high prognostications score, and high in-hospital morbidity.
Human ; Kidney Failure, Chronic ; End-stage Renal Disease ; Acute Coronary Syndrome ; Myocardial Infarction
3.Evaluation of anti-angiogenic activity of the acetone leaf extract of Annona squamosa Linn. (Annonaceae).
Katrina D. Loretizo ; Daisy-mae O. Alegado-Bagaoisan ; Paola Cyra M. Acosta ; Francis Gabriel D. Chua ; Gwyneth Beatrice B. Delaganar ; Rogie Royce Z. Carandang ; Kevin Jace A. Miranda
Acta Medica Philippina 2026;60(4):71-78
OBJECTIVE
The study aimed to investigate the potential anti-angiogenic effects of acetone extracts from Annona squamosa leaves in vivo.
METHODSCrude acetone extract of A. squamosa leaves was prepared via simple maceration. Physicochemical and phytochemical screening of the extract were also performed. The anti-angiogenic effect of A. squamosa was assessed using in vivo chorioallantoic membrane (CAM) assay, with quantitative analysis performed using ImageJ software (U. S. National Institutes of Health, Bethesda, Maryland, USA). The eggs were treated with 1000 ppm, 500 ppm, and 250 ppm doses of the extract. Quercetin was utilized as the positive control while distilled water was used as the negative control.
RESULTSThe results of the study showed the presence of alkaloids, flavonoids, tannins, and phenolic compounds in the leaves of A. squamosa. CAM assay revealed a significant (PCONCLUSION
The acetone extract of A. squamosa leaves possesses anti-angiogenic properties in vivo, suggesting its potential for developing anti-angiogenic agents. Further research to identify and isolate the specific bioactive compounds responsible for this activity is recommended.
Plants ; Alkaloids ; Flavonoids ; Phytochemicals
4.Sedation practices for intubated patients with COVID-19 and non-COVID-19 acute respiratory distress syndrome and its effects on clinical outcomes.
Patricia T. Pintac ; Albert B. Albay Jr.
Acta Medica Philippina 2026;60(4):79-88
OBJECTIVE
To compare the sedation practices of adult intubated patients with COVID-19-related Acute Respiratory Distress Syndrome (C-ARDS) and ARDS from other causes, and their impact on clinical outcomes in a tertiary hospital.
METHODSWe performed a retrospective cohort on the sedation practices of adult intubated patients with C-ARDS and non-C-ARDS admitted to the intensive care unit of a tertiary hospital from January 2021 to December 2021. Electronic medical records were reviewed to obtain sedative use, sedative dosages, clinical outcomes, and complications.
RESULTSAmong the 150 included patients, 112 had C-ARDS, and 38 had non-C-ARDS. The C-ARDS group showed a significant difference with the non-C-ARDS group in terms of BMI (24.11 vs. 21.09 kg/m2, p < 0.001), use of higher PEEP (16 vs. 10, p < 0.001), and prone positioning (40.18% vs 2.63%, p < 0.01). In terms of sedation practice, C-ARDS patients targeted deeper RASS scores (p=0.038), with a significantly higher proportion receiving more than one sedative (82.14% vs. 18.42, p < 0.001) than non-C-ARDS patients. Sedation doses for midazolam (78 mg/d vs. 36 mg/d; p=0.01) and propofol (mean 2626±1312.97 mg/d vs. 1742±380.99 mg/d; p=0.007), were significantly higher among C-ARDS versus non-C-ARDS group. Duration of hospitalization (9 vs. 20 days; p < 0.001) and ventilator use (7 vs. 14.50 days; p < 0.001) were significantly shorter in the C-ARDS group, albeit with a high mortality (100% vs. 89.47%; p=0.004). Shock-requiring pressor was significantly associated with multiple sedation use [OR=15.11 (1.52-2032.89); p=0.017] and combination use of benzodiazepine and non-benzodiazepines [OR=11.51 (1.17-1541.91); p=0.034] in the C-ARDS but not the C-ARDS group.
CONCLUSIONPatients with C-ARDS had higher sedation requirements in terms of dosage and number of sedatives. The use of multiple sedatives was significantly associated with shock-requiring pressor. We recommend the development of a sedation protocol to guide sedation practices and monitoring of complications in the critically ill.
Human ; Covid-19 ; Intensive Care Units
5.The efficacy of oral solution of magnesium sodium potassium sulfate in bowel preparation before colonoscopy
Xin HUANG ; Rujie YANG ; Feng QIN ; Shilian ZHANG ; Xin WU ; Xiaoyan YIN
Journal of Pharmaceutical Practice and Service 2026;44(2):85-87
<b>Objectiveb> To explore the efficacy and safety of oral solution of magnesium sodium potassium sulfate in bowel preparation before colonoscopy. <b>Methodsb> Patients who planned to undergo colonoscopy at the digestive department of the Ninth People’s Hospital, affiliated to School of Medicine of Shanghai Jiao Tong University from January 2023 to August 2023 were selected and eligible subjects were divided into two groups: Group A took polyethylene glycol (PEG) and Group B took oral solution of magnesium sodium potassium sulfate (OSS). The quality, drug tolerance, and safety of intestinal preparation were evaluated. The quality of bowel preparation was evaluated by the boston bowel preparation scale (BBPS). <b>Resultsb> The right colon BBPS score of Group B was (2.39±0.82) points, which was significantly higher than of Group A (2.11±0.43) points (P<0.05). The overall score of Group B was higher than that of Group A (P<0.05). OSS was easier to take than PEG, with a good taste and overall sensation. Patients were willing to use OSS to clean their bowels even when they were willing to undergo another examination (P<0.05). There was a significant difference in nausea and vomiting symptoms between the two groups (P<0.05), and there were no significant changes in renal function and electrolytes before and after medication in the two groups of patients. <b>Conclusionb> OSS had a higher quality of bowel cleaning and was easier for patients to accept.
6.A survey on the operational management issues of drug clinical trials in the yangtze river delta region
Yougen WU ; Yuting GU ; Ju XIA ; Qingqing QIAN
Journal of Pharmaceutical Practice and Service 2026;44(2):103-107
<b>Objectiveb> To analyze the problems in the operation and management of drug clinical trials and put forward targeted suggestion. <b>Methodsb> An electronic questionnaire survey was conducted among medical staff in about 80 hospitals in the yangtze river delta region. <b>Resultsb> 606 valid questionnaires were received. 71% of the respondents expressed their willingness to study and participate in drug clinical trials. There were significant differences in the cognitive demands, willingness and motivation of the respondents with different occupations and educational backgrounds about the drug clinical trial work (P<0.05). During the operation of drug clinical trials, respondents reported the main factors affecting the quality of clinical trials which including good clinical practice (GCP) awareness and subjective enthusiasm of investigators (response rate 27%), job stability of supervisors and research coordinators (27%), compliance of subjects (45%), quality control of the whole process of the circulation of test drugs, medical devices and biological samples (52%), and the informatization level of clinical trial institutions (30%). <b>Conclusionb> Hospitals, institutions and project teams could take measures to cultivate and stabilize the drug clinical trial talent team, improve the quality management system of drug clinical trials, improve work efficiency, and promote the high-quality development of drug clinical trials in medical institutions.
7.Asymptomatic Rotator Cuff Tendinopathy in Elderly Diabetics: Is Routine Magnetic Resonance Imaging Evaluation of the Shoulder Warranted?
Gupta TP ; Sirohi B ; Jafri MA ; Rai S
Malaysian Orthopaedic Journal 2026;20(No. 1):17-
Introduction: The occurrence of rotator cuff tendinopathy,
which is invariably symptomatic, increases as populations
age, being largely observed among patients with diabetes.
The objective of the present study is to find out the
occurrence of rotator cuff tendinopathy in elderly diabetic
patients who were asymptomatic, composed of healthy
individuals and those with diabetes mellitus.
Materials and methods: The participants in this study
included 87 elderly diabetic patients and 56 controls (mean
age: 69.3±4.9 and 71.8±3.6, respectively), who were
asymptomatic from shoulder. All patients, including,
underwent shoulder MRI examination using 1.5 tesla MRI.
Results: We recorded greater tendons thickness in the
diabetic patients as compared with the controls
(supraspinatus tendon: 6.6±0.7mm vs 5.3±0.8mm, p<0.001;
biceps tendon: 3.9±0.7mm vs 3.1±0.8mm, p<0.002).
Moreover, higher incidence of supraspinatus tendon tear was
noted in diabetics as compared to biceps tendon (major tears:
32 (36.7%) vs 6 (10.7%), p=0.052; minor tears: 51 (58.6%)
vs 11 (19.6%), p=0.032).
Conclusions: The present study suggests that age-related
rotator cuff tendinopathy is more prevalent among patients
with diabetes. Therefore, MRI is an investigation of choice
for early detection i.e., at pre-symptomatic stages of rotator
cuff tendinopathy, as the patients may develop symptoms
later.
Keywords:
asymptomatic
8.The advantages and disadvantages of CRISPR-Cas9 technology in screening tumor therapeutic targets
Chinese Journal of Cancer Biotherapy 2026;33(1):99-104
[摘 要] 成簇规律间隔短回文重复系统及相关蛋白9(CRISPR-Cas9)作为高效、特异的基因编辑工具,已在人类疾病,尤其是肿瘤治疗领域被广泛研究。本文系统梳理CRISPR-Cas9的特点、机制与优势,重点分析该技术在肿瘤治疗靶点筛选中的新突破与前沿应用,阐明CRISPR-Cas9在肿瘤生物治疗靶点筛选技术中的核心地位。同时,直面CRISPR-Cas9技术筛选靶点在当前临床研究中面临的诸多挑战,深入探讨其局限性和关键瓶颈问题,展望其优化策略和未来发展趋势。
9.SNORA71A regulates the malignant biological behaviors of esophageal squamous cell carcinoma TE-1 cells via the TLR3/PD-L1 expression
SHEN Supenga ; LIANG Jiaa ; CAO Shirua ; ZHAO Yanb ; DONG Zhiminga ; LIU Leic
Chinese Journal of Cancer Biotherapy 2026;33(2):147-154
[摘 要] 目的:探讨核仁小RNA(snoRNA)71A通过TLR3/PD-L1通路对食管鳞状细胞癌(ESCC)细胞增殖、迁移及侵袭能力的影响。方法:qPCR检测52例ESCC患者的配对肿瘤组织、癌旁组织,以及人ESCC细胞中SNORA71A的表达情况。将反义寡核苷酸(SNORA71A-ASO-29、SNORA71A-ASO-102和NC-ASO)或小干扰RNA(siTLR3、siTLR3-NC)分别转染至人ESCC TE-1细胞,分别记为SNORA71A-ASO1组、SNORA71A-ASO2组、NC-ASO组及siTLR3组、siNC组。另外将过表达质粒pcDNA3.1-SNORA71A和pcDNA3.1空载体质粒分别转染至TE-1细胞,分别记为SNORA71A组和Vector组。细胞功能学实验(MTS实验、划痕愈合实验,以及Transwell侵袭实验)评估各组细胞在敲低或过表达SNORA71A后增殖、迁移和侵袭能力的变化。高通量转录组测序筛选SNORA71A下游作用靶基因,基因本体论(GO)和京都基因与基因组百科全书(KEGG)功能富集分析预测SNORA71A下游作用靶基因可能参与的生物学过程和信号通路。qPCR检测测序筛选出的下游作用靶基因TLR3在ESCC组织以及细胞中的表达。同时,qPCR和WB检测TE-1细胞在敲低或过表达TLR3后PD-L1 mRNA和蛋白质表达变化。细胞功能学实验检测TLR3敲低对SNORA71A所促进的TE-1细胞恶性生物行为(增殖、迁移、侵袭)的影响。结果:在52例ESCC患者的肿瘤组织以及ESCC细胞中SNORA71A表达均呈高水平(P < 0.01或P < 0.05)。敲低SNORA71A抑制TE-1细胞增殖、迁移和侵袭(P < 0.01或P < 0.05),过表达SNORA71A则促进TE-1细胞增殖、迁移和侵袭(P < 0.01或P < 0.05)。高通量转录组测序筛选到TLR3为SNORA71A下游作用靶基因。TLR3在ESCC组织以及TE-1细胞中呈低表达(P < 0.01或P < 0.05)。TLR3正向调控PD-L1 mRNA和蛋白质表达(P < 0.01或P < 0.05)。细胞功能学实验中,TLR3可以部分削弱SNORA71A对PD-L1表达的调控(P < 0.01)。结论:SNORA71A通过调控TLR3/PD-L1通路调节TE-1细胞增殖、迁移和侵袭。
10.Detection of a Serratia sarumanii outbreak in neonatal intensive care units using SaTScan and whole genome sequencing, Philippines, 2022
Giselle V Godin ; Sonia B Sia ; Ferissa B Ablola ; June M Gayeta ; Marietta L Lagrada ; Polle Krystle V Macaranas ; Agnettah M Olorosa ; Janziel Fiel Palarca ; Manuel C Jamoralin, Jr ; June Janice Borlasa ; Ma Fe Laren B Gacho ; Rica Marie B Andico ; Ida Marrione Q Arriola ; Jo-Anne J Lobo ; Melanie B Adolfo ; Jessica Anne A Dumalag ; Joel T Gallardo ; Ma Delta S Aguilar ; Allyne M Aguelo ; Charlotte V Bañ ; es ; Genelynne J Beley
Western Pacific Surveillance and Response 2026;17(1):13-21
Objective: This study aimed to demonstrate the benefits of using SaTScan (Boston, MA, USA), a cluster-detection software programme, and whole genome sequencing to investigate a suspected outbreak of Serratia marcescens infections in a tertiary government hospital in the southern Philippines. The hospital is part of the national Antimicrobial Resistance Surveillance Program’s network of sentinel sites.
Methods: The investigation followed national outbreak investigation protocols. In May 2022, when evaluation of daily hospital laboratory census data revealed an increase in the number of Serratia species in the hospital, an alert was triggered. A concurrent, routine SaTScan analysis of the hospital’s surveillance data by the Antimicrobial Resistance Surveillance Reference Laboratory confirmed a cluster of cases. The Reference Laboratory requested isolates from clinical specimens from the hospital for confirmation of bacterial identification, antimicrobial susceptibility testing and whole genome sequencing.
Results: Six isolates were submitted for genomic analysis, two of which were from the identified cluster. Although originally identified as S. marcescens, five of the isolates were subsequently confirmed as S. sarumanii. Phylogenetic analysis showed that the two isolates from the cluster were closely related and belonged to the same clade, which may suggest a common source. Three antimicrobial resistance genes were identified, but their phenotypic expression was limited, with one isolate exhibiting resistance mechanisms.
Discussion: This study highlighted the utility of SaTScan for the early detection of potential disease outbreaks. The use of whole genome sequencing enhanced the investigation by enabling the analysis of potential transmission pathways at the genetic level, identification of the outbreak source and the detection of novel species.


Result Analysis
Print
Save
E-mail